{"count": 8, "results": [{"_id": "24878085", "pmid": 24878085, "title": "[Effect of metformin addition to an acute lymphoblastic leukemia chemotherapy treatment].", "journal": "Rev Med Inst Mex Seguro Soc", "authors": ["Ramos-Peñafiel CO", "Martínez-Murillo C", "Santoyo-Sánchez A", "Jiménez-Ponce F", "Rozen-Fuller E", "Collazo-Jaloma J", "Olarte-Carrillo I", "Martínez-Tovar A"], "date": "2014-05-01T00:00:00Z", "meta_date_publication": "2014 May-Jun", "meta_volume": "52", "meta_issue": "3", "meta_pages": "270-5", "score": 50069.82, "text_hl": "[Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ addition to an @<m>DISEASE_Precursor_Cell_Lymphoblastic_Leukemia_Lymphoma</m> @DISEASE_MESH:D054198 @@@acute lymphoblastic leukemia@@@ chemotherapy treatment].", "citations": {"NLM": "Ramos-Peñafiel CO, Martínez-Murillo C, Santoyo-Sánchez A, Jiménez-Ponce F, Rozen-Fuller E, Collazo-Jaloma J, Olarte-Carrillo I, Martínez-Tovar A. [Effect of metformin addition to an acute lymphoblastic leukemia chemotherapy treatment]. Rev Med Inst Mex Seguro Soc. 2014 May-Jun;52(3):270-5. PMID: 24878085", "BibTeX": "@article{24878085, title={[Effect of metformin addition to an acute lymphoblastic leukemia chemotherapy treatment].}, author={Ramos-Peñafiel CO and Martínez-Murillo C and Santoyo-Sánchez A and Jiménez-Ponce F and Rozen-Fuller E and Collazo-Jaloma J and Olarte-Carrillo I and Martínez-Tovar A}, journal={Rev Med Inst Mex Seguro Soc}, volume={52}, number={3}, pages={270-5}}"}}, {"_id": "30534883", "pmid": 30534883, "title": "[Effect of metformin added to chemotherapy on the survival of patients with acute lymphoblastic leukemia].", "journal": "Rev Med Chil", "authors": ["Ramos Peñafiel C", "Olarte Carrillo I", "Ceron Maldonado R", "Miranda Peralta E", "Rozen Fuller E", "Kassack Ipiña JJ", "Centeno Cruz F", "Collazo Jaloma J", "Martínez Tovar A"], "date": "2018-07-01T00:00:00Z", "doi": "10.4067/s0034-98872018000700846", "meta_date_publication": "2018 Jul", "meta_volume": "146", "meta_issue": "7", "meta_pages": "846-853", "score": 50065.47, "text_hl": "[Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ added to chemotherapy on the survival of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Precursor_Cell_Lymphoblastic_Leukemia_Lymphoma</m> @DISEASE_MESH:D054198 @@@acute lymphoblastic leukemia@@@].", "citations": {"NLM": "Ramos Peñafiel C, Olarte Carrillo I, Ceron Maldonado R, Miranda Peralta E, Rozen Fuller E, Kassack Ipiña JJ, Centeno Cruz F, Collazo Jaloma J, Martínez Tovar A. [Effect of metformin added to chemotherapy on the survival of patients with acute lymphoblastic leukemia]. Rev Med Chil. 2018 Jul;146(7):846-853. PMID: 30534883", "BibTeX": "@article{30534883, title={[Effect of metformin added to chemotherapy on the survival of patients with acute lymphoblastic leukemia].}, author={Ramos Peñafiel C and Olarte Carrillo I and Ceron Maldonado R and Miranda Peralta E and Rozen Fuller E and Kassack Ipiña JJ and Centeno Cruz F and Collazo Jaloma J and Martínez Tovar A}, journal={Rev Med Chil}, volume={146}, number={7}, pages={846-853}}"}}, {"_id": "24009772", "pmid": 24009772, "pmcid": "PMC3751848", "title": "Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts", "journal": "PLoS One", "authors": ["Leclerc GM", "Leclerc GJ", "Kuznetsov JN", "DeSalvo J", "Barredo JC"], "date": "2013-08-23T00:00:00Z", "doi": "10.1371/journal.pone.0074420", "meta_date_publication": "2013", "meta_volume": "8", "meta_issue": "8", "meta_pages": "e74420", "score": 50063.426, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Induces Apoptosis through @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@-Dependent Inhibition of UPR Signaling in @<m>DISEASE_Precursor_Cell_Lymphoblastic_Leukemia_Lymphoma</m> @DISEASE_MESH:D054198 @@@ALL@@@ Lymphoblasts", "citations": {"NLM": "Leclerc GM, Leclerc GJ, Kuznetsov JN, DeSalvo J, Barredo JC. Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts PLoS One. 2013;8(8):e74420. PMID: 24009772", "BibTeX": "@article{24009772, title={Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts}, author={Leclerc GM and Leclerc GJ and Kuznetsov JN and DeSalvo J and Barredo JC}, journal={PLoS One}, volume={8}, number={8}, pages={e74420}}"}}, {"_id": "23823111", "pmid": 23823111, "title": "Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia.", "journal": "J Pediatr Hematol Oncol", "authors": ["Bostrom B", "Uppal P", "Chu J", "Messinger Y", "Gandrud L", "McEvoy R"], "date": "2013-10-01T00:00:00Z", "doi": "10.1097/MPH.0b013e31829cdeba", "meta_date_publication": "2013 Oct", "meta_volume": "35", "meta_issue": "7", "meta_pages": "504-8", "score": 50061.527, "text_hl": "Safety and efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for therapy-induced @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ in children with @<m>DISEASE_Precursor_Cell_Lymphoblastic_Leukemia_Lymphoma</m> @DISEASE_MESH:D054198 @@@acute lymphoblastic leukemia@@@.", "citations": {"NLM": "Bostrom B, Uppal P, Chu J, Messinger Y, Gandrud L, McEvoy R. Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2013 Oct;35(7):504-8. PMID: 23823111", "BibTeX": "@article{23823111, title={Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia.}, author={Bostrom B and Uppal P and Chu J and Messinger Y and Gandrud L and McEvoy R}, journal={J Pediatr Hematol Oncol}, volume={35}, number={7}, pages={504-8}}"}}, {"_id": "22249159", "pmid": 22249159, "pmcid": "PMC3282089", "title": "AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications", "journal": "Oncotarget", "authors": ["Vakana E", "Platanias LC"], "date": "2011-12-01T00:00:00Z", "doi": "10.18632/oncotarget.413", "meta_date_publication": "2011 Dec", "meta_volume": "2", "meta_issue": "12", "meta_pages": "1322-8", "score": 50057.688, "text_hl": "The potential for future clinical-translational applications of @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activators such as AICAR, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Resveratrol @CHEMICAL_MESH:D000077185 @@@resveratrol@@@ for the treatment of @DISEASE_Leukemia_Myelogenous_Chronic_BCR_ABL_Positive @DISEASE_MESH:D015464 @@@chronic myelogenous leukemia@@@ (@DISEASE_Leukemia_Myelogenous_Chronic_BCR_ABL_Positive @DISEASE_MESH:D015464 @@@CML@@@) and @<m>DISEASE_Precursor_Cell_Lymphoblastic_Leukemia_Lymphoma</m> @DISEASE_MESH:D054198 @@@Ph+ acute lymphoblastic leukemia@@@ (@<m>DISEASE_Precursor_Cell_Lymphoblastic_Leukemia_Lymphoma</m> @DISEASE_MESH:D054198 @@@ALL@@@) are discussed.", "citations": {"NLM": "Vakana E, Platanias LC. AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications Oncotarget. 2011 Dec;2(12):1322-8. PMID: 22249159", "BibTeX": "@article{22249159, title={AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications}, author={Vakana E and Platanias LC}, journal={Oncotarget}, volume={2}, number={12}, pages={1322-8}}"}}, {"_id": "26186064", "pmid": 26186064, "title": "The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell.", "journal": "Anticancer Drugs", "authors": ["Shi R", "Lin J", "Gong Y", "Yan T", "Shi F", "Yang X", "Liu X", "Naren D"], "date": "2015-10-01T00:00:00Z", "doi": "10.1097/CAD.0000000000000266", "meta_date_publication": "2015 Oct", "meta_volume": "26", "meta_issue": "9", "meta_pages": "913-22", "score": 50056.117, "text_hl": "Overall, our data suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ represents a promising and attractive agent for @<m>DISEASE_Precursor_Cell_Lymphoblastic_Leukemia_Lymphoma</m> @DISEASE_MESH:D054198 @@@Ph+ALL@@@ or @DISEASE_Leukemia_Myelogenous_Chronic_BCR_ABL_Positive @DISEASE_MESH:D015464 @@@CML@@@ therapy. ", "citations": {"NLM": "Shi R, Lin J, Gong Y, Yan T, Shi F, Yang X, Liu X, Naren D. The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell. Anticancer Drugs. 2015 Oct;26(9):913-22. PMID: 26186064", "BibTeX": "@article{26186064, title={The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell.}, author={Shi R and Lin J and Gong Y and Yan T and Shi F and Yang X and Liu X and Naren D}, journal={Anticancer Drugs}, volume={26}, number={9}, pages={913-22}}"}}, {"_id": "24841876", "pmid": 24841876, "title": "Metformin and cancer.", "journal": "Rev Diabet Stud", "authors": ["Vallianou NG", "Evangelopoulos A", "Kazazis C"], "date": "2013-01-01T00:00:00Z", "doi": "10.1900/RDS.2013.10.228", "meta_date_publication": "2013 Winter", "meta_volume": "10", "meta_issue": "4", "meta_pages": "228-35", "score": 50055.62, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@.", "citations": {"NLM": "Vallianou NG, Evangelopoulos A, Kazazis C. Metformin and cancer. Rev Diabet Stud. 2013 Winter;10(4):228-35. PMID: 24841876", "BibTeX": "@article{24841876, title={Metformin and cancer.}, author={Vallianou NG and Evangelopoulos A and Kazazis C}, journal={Rev Diabet Stud}, volume={10}, number={4}, pages={228-35}}"}}, {"_id": "29856514", "pmid": 29856514, "title": "A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin.", "journal": "Pediatr Blood Cancer", "authors": ["Trucco M", "Barredo JC", "Goldberg J", "Leclerc GM", "Hale GA", "Gill J", "Setty B", "Smith T", "Lush R", "Lee JK", "Reed DR"], "date": "2018-09-01T00:00:00Z", "doi": "10.1002/pbc.27224", "meta_date_publication": "2018 Sep", "meta_volume": "65", "meta_issue": "9", "meta_pages": "e27224", "score": 50049.02, "text_hl": "A phase I window, dose escalating and safety trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in combination with induction chemotherapy in relapsed refractory @<m>DISEASE_Precursor_Cell_Lymphoblastic_Leukemia_Lymphoma</m> @DISEASE_MESH:D054198 @@@acute lymphoblastic leukemia@@@: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ with induction chemotherapy of @CHEMICAL_Vincristine @CHEMICAL_MESH:D014750 @@@vincristine@@@, @CHEMICAL_Dexamethasone @CHEMICAL_MESH:D003907 @@@dexamethasone@@@, @CHEMICAL_pegaspargase @CHEMICAL_MESH:C042705 @@@PEG-asparaginase@@@, and @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@doxorubicin@@@.", "citations": {"NLM": "Trucco M, Barredo JC, Goldberg J, Leclerc GM, Hale GA, Gill J, Setty B, Smith T, Lush R, Lee JK, Reed DR. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Pediatr Blood Cancer. 2018 Sep;65(9):e27224. PMID: 29856514", "BibTeX": "@article{29856514, title={A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin.}, author={Trucco M and Barredo JC and Goldberg J and Leclerc GM and Hale GA and Gill J and Setty B and Smith T and Lush R and Lee JK and Reed DR}, journal={Pediatr Blood Cancer}, volume={65}, number={9}, pages={e27224}}"}}]}